Figure 2
From: Management of advanced colorectal cancer: state of the art
Expansion of the treatment choices for patients with advanced CRC (Rougier et al, 1998; de Gramont et al, 2000; Douillard et al, 2000; Maughan et al, 2002; Cunningham et al, 2004; Hurwitz et al, 2004; Tournigand et al, 2004) Iri=irinotecan; Ox=oxaliplatin; Cap=capecitabine; bev=bevacizumab; cet=cetuximab; BSC=best supportive care.
